I'm feeling a bit down about this news 
... I mean, it's like we're taking away the safety net for pharmaceutical companies that invest so much in research and development 
. It's not just about the money; it's about the lives they're trying to save or improve with their medications. Do we really need to be pushing them to cut costs at the expense of innovation? 
And what about all the patients who rely on these medications to manage their weight and health conditions? Will they have access to affordable options now that patents are expiring? It's a bit unsettling, to say the least
. Maybe we need to rethink our approach to pricing and patent protections, rather than just going through the motions .
... I mean, it's like we're taking away the safety net for pharmaceutical companies that invest so much in research and development . It's not just about the money; it's about the lives they're trying to save or improve with their medications. Do we really need to be pushing them to cut costs at the expense of innovation? And what about all the patients who rely on these medications to manage their weight and health conditions? Will they have access to affordable options now that patents are expiring? It's a bit unsettling, to say the least
. Maybe we need to rethink our approach to pricing and patent protections, rather than just going through the motions .
just saw that Novo Nordisk is revising down its revenue forecast for 2026! 
they're expecting a 5-13% decline in sales? That's crazy! 
I guess the Trump admin's push for lower weight loss drug prices has caught up with them. 
but at the same time, it's just gonna lead to more generic versions of their meds being made cheaper 
which means even less sales for them.
their Mounjaro jab is looking like a game changer 
and I'm excited to see how that plays out in the coming years 
hoping more companies can adapt to these changes without losing too much steam 
mike doustdar is blaming the us price cuts agreed upon by trump tho 
i get it, prices dropped from $1k/month to $350/month, that's a big hit 
they're keepin patent protection for semaglutide til 2033 lol, like, generic drugmakers r gonna have a field day 